|
Research & Industry
-
Company pursues first lymphoma drug for dogs
1/2/2013
$1.5 million raised to fund effort
-
Injectable sterilant for dogs returning to market
10/19/2012
New owner must overcome drug’s rocky history
-
Dog breed genetic tests put to the test
7/10/2012
Science is solid but results aren’t precise
-
Pfizer-Zoetis transition shouldn't impact veterinarians, industry expert says
6/20/2012
Animal health division to be independent company by July 2013
-
Independent voice of digital radiology silenced?
10/13/2011
DVMInsight's sale to Idexx viewed by some as contradiction
-
Search and rescue dogs show no medical, behavioral effects tied to 9/11
9/11/2011
Research on canine responders continues
-
Entest to use veterinary practices as revenue driver, research venue
8/23/2011
Concerns about setup point to potential conflicts of interest
-
Feral cat management paper grabs attention of veterinarians
12/23/2010
AAHA pans paper's passage on how to shoot feral cats
-
AVMA condemns activists targeting UC Davis researchers
12/1/2010
-
NAS veterinary workforce study nears release
10/28/2010
Stakeholders expect report to shed light on supply and demand in America
-
Bayer opens flea product sales to retail outlets
2/10/2010
Citing diversion, company ends policy of selling only through veterinarians
-
Scrutiny emerges concerning conflicts of interest in veterinary literature
1/26/2010
Sponsorship abuses uncovered in human medical journals spark concerns among DVMs
-
Veterinarian uses stem cells to treat spinal cord disease
10/2/2009
UC-Davis professor embraces on new research model
-
Pet cloning market proves hit or miss
9/29/2009
Company closes its doors as competitor expands
-
Sanofi makes $4-billion deal with Merck for Merial
7/31/2009
Ultimate plan could create world's largest animal-health company
-
Revision to AVMA’s policy on acquiring research animals gets ax
7/13/2009
'Pound seizure' illegal in 17 states
-
VCA Antech expands its foray into medical technology by buying Eklin
7/11/2009
Promises to continue supporting VIA, Eklin’s practice management software
-
UC Davis opens stem-cell program for horses
6/23/2009
Stem-cell therapy: a highly active field
-
FDA green lights Felimazole to treat feline hyperthyroidism
6/11/2009
Methimazole used off-label by veterinarians since 1970s
-
Cats susceptible to neurological problems when fed irradiated diets
6/8/2009
Australian outbreak is the latest of at least three
-
New mystery arises in cases of Fanconi-like syndrome
5/28/2009
Australian researchers consider possible link to dental chews
-
Economic downturn hits veterinary practices
3/11/2009
New VIN survey results anticipated
-
Merck buys Schering-Plough
3/11/2009
-
Blockbuster Pfizer-Wyeth deal stirs veterinary medicine
2/9/2009
Merger muddies outlook for Fort Dodge Animal Health
-
Can we eat it?
1/23/2009
Pet food 'human grade' claim examined
-
Banfield may share data with UC-Davis
1/13/2009
New food safety center envisioned
-
Fuel prices drop, yet surcharges remain for diagnostic services
12/18/2008
DVMs push back; Antech drafts letter to explain fees
-
Fanconi-like cases continue in Australia
12/15/2008
Company recalls chicken treats made in China
-
Self-made billionaire offers $75-million motivator to curb pet overpopulation
10/23/2008
Award goes to the scientist who invents non-surgical, safe means to sterilize dogs, cats
-
Researchers seek dogs for chronic renal disease study
10/1/2008
LSU investigates statin's power to slow disease
-
Veterinarian who exposed pet food toxicity earns nomination for federal award
7/30/2008
Dr. Renate Reimschussel honored for discovering the chemical reaction that spurred last year’s crisis
-
FDA approves antimicrobial for aquaculture uses
7/11/2008
Supplemental OK involves Terramycin 200
|
|
Search and rescue dogs show no medical, behavioral effects tied to 9/11
|
September 11, 2011
By: Phyllis DeGioia
For The VIN News Service
A decade after the deadliest terror attacks in U.S. history, research continues on the health of search and rescue (S&R) dogs that were deployed to 9/11 disaster sites.
While many human responders suffer from respiratory illnesses, studies show that medical setbacks for their canine counterparts are almost nonexistent.
Studies from the University of Pennsylvania School of Veterinary Medicine were published in 2010, and twice in 2004. Each revealed that the dogs did not have any adverse health or behavioral consequences tied to the experience.
This conclusion holds true for S&R dogs that were at the World Trade Center (WTC), the Pentagon and the Fresh Kills Landfill on Staten Island that took debris from the collapsed World Trade Center.
Conducted by Penn researchers, the studies compared 95 S&R dogs that worked at 9/11 disaster sites to a control group of 55 S&R dogs that did not work in those areas. The death and cancer rates in the 9/11 dogs is the same as those in the control group, although the 9/11 dogs had a slightly longer lifespan of 12.5 years compared with 11.8 years, the study showed. Soon after the deployment ended, elevated liver values (bilirubin concentration and alkaline phosphatase activity) indicated that the 9/11 dogs were filtering toxicants, but those levels soon became normal. Exposure to air pollutants at the site was not associated with lung or sinus damage in the dogs. One of the 2004 studies found no significant differences in behavior between the 9/11 and control groups.
Human responders, however, have been found to suffer from lasting health problems tied to their deployment at 9/11 disaster sites. The authors’ interpretation of a study published in the Sept. 3, 2011, issue of “The Lancet” states that “nine years after the 9/11 WTC attacks, rescue and recovery workers continue to have a substantial burden of physical and mental health problems.”
 Dr. Cynthia Otto researches the health of search and rescue dogs that worked 9/11 disaster sites.
Photo courtesy of University of Pennsylvania School of Veterinary Medicine. Cynthia M. Otto, DVM, PhD, DACVECC, spearheaded these studies. She is a board-certified emergency and critical care veterinarian and a tenured associate professor of critical care at Penn. Otto cared for dogs at Ground Zero.
Otto addressed her research findings with the VIN News Service. Here is an excerpt of that interview:
Q. How has the veterinary community responded to these studies?
A. We haven’t had a whole lot of response because the news is good.
Q. Was the conclusion a surprise for you?
A. It was absolutely a surprise, we were expecting problems. We wanted to know if post-traumatic stress syndrome (PTSD), all of these health problems, were real. At Ground Zero there were lots of rumors that circulated about S&R dogs after Oklahoma City — rumor had it that six months later they all died of Salmonella. We knew it was ridiculous, and we knew we needed data.
Q. Did something you expect to see not happen?
A. We expected respiratory problems, a higher rate of cancer.
Q. Do you plan to continue research on this topic, and if so, on what area will you concentrate?
A. Absolutely. It is the legacy of 9/11 working dogs. It’s research on health, genetics and conditioning, on every piece of what makes working dogs successful. We want to try to put it together and move things forward. We have something funded by the AKC Companion Animal Fund. One goal is detecting DNA to get a DNA bank of successful detection dogs. Another goal is a breeding and training site: How do we apply genetic findings, physical conditioning, how do we optimize these dogs?
Q. How does this information contribute to veterinary medicine? What do you think it contributes to human medicine?
A. We found statistically significant changes at year 5 on heart size, and there are some cardiac issues in the human responders. We saw a spike in immunoglobulins in the first year. We’re paying attention to cancer with particular attention to the immune system, but it’s still early. We still have a fair number of control dogs left because they were a year younger. The impact for humans is that we may have some sentinels of disease here. Perhaps they’re subtle, but it might make them aware of subtle differences. The psychological study involved humans and dogs. S&R dogs do not get PTSD, but some military dogs get it.
 At Ground Zero, Dr. Cynthia Otto kneels behind personnel from four search and rescue teams with whom she worked. Photo courtesy of University of Pennsylvania School of Veterinary Medicine Q. Even though your studies say there were no long-term health effects, you saw enlarged hearts. Isn’t that a long-term effect?
A. There are not obvious long-term effects on their health. We did see changes in their heart size but that was not associated with any increase in overt heart disease, so there are some differences that are relatively subtle which may have a health impact but we couldn't measure an actual effect on the dog's performance.
Q. How does it feel delving into the medical experiences of these particular S&R dogs?
A. I’m so proud of them. We have a psychologist we were working with. The handlers are very dedicated people; the bond they have with their dogs is incredible. The bond gives them resilience to handle the stress. The impact the dogs have on handlers is significant.
Sorry, but you do not have authorization to view the news article you requested.
|
|

Search VIN news
All news categories
Follow us
|